日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of pasireotide on postoperative pancreatic fistulas following distal resections

帕瑞肽对远端胰腺切除术后胰瘘的影响

Vuorela, Tiina; Mustonen, H; Kokkola, A; Haglund, C; Seppanen, H

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

结直肠癌、胃癌和胃肠道间质瘤的肿瘤标志物:欧洲肿瘤标志物小组2014年指南更新

Duffy, M J; Lamerz, R; Haglund, C; Nicolini, A; Kalousová, M; Holubec, L; Sturgeon, C

Erratum to: “Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors

更正:“神经肽S受体1(NPSR1)激活癌症相关通路,并在神经内分泌肿瘤中广泛表达”

Herr, Timothy M; Bielinski, Suzette J; Bottinger, Erwin; Brautbar, Ariel; Brilliant, Murray; Chute, Christopher G; Cobb, Beth L; Denny, Joshua C; Hakonarson, Hakon; Hartzler, Andrea L; Hripcsak, George; Kannry, Joseph; Kohane, Isaac S; Kullo, Iftikhar J; Lin, Simon; Manzi, Shannon; Marsolo, Keith; Overby, Casey Lynnette; Pathak, Jyotishman; Peissig, Peggy; Pulley, Jill; Ralston, James; Rasmussen, Luke; Roden, Dan M; Tromp, Gerard; Uphoff, Timothy; Weng, Chunhua; Wolf, Wendy; Williams, Marc S; Starren, Justin; Pulkkinen, V; Ezer, S; Sundman, L; Hagström, J; Remes, S; Söderhäll, C; Greco, D; Haglund, C; Kere, J; Arola, J

MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

MMP-2 与 COX-2 和胃癌生存率相关,但 MMP-9 不相关

Mrena J, Wiksten J-P, Nordling S, Kokkola A, Ristimäki A, Haglund C

Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases

比较新型肿瘤标志物 CA 242 与 CA 19-9、CA 50 和癌胚抗原 (CEA) 在消化道疾病中的作用

Kuusela, P; Haglund, C; Roberts, P J

Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases

在胃肠道疾病患者中,比较新型肿瘤标志物CA-50与癌胚抗原(CEA)和甲胎蛋白(AFP)的价值

Kuusela, P; Haglund, C; Roberts, P J; Jalanko, H

Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis

胰腺肿瘤和胰腺炎组织标本中的胃肠道癌症相关抗原 CA 19-9

Haglund, C; Lindgren, J; Roberts, P J; Nordling, S

Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases

在患有上消化道疾病的患者中,比较一种新的肿瘤标志物 CA 19-9 与甲胎蛋白和癌胚抗原

Jalanko, H; Kuusela, P; Roberts, P; Sipponen, P; Haglund, C A; Mäkelä, O